Resources

Phase 1 mRNA HIV Vaccine Trials

A snapshot of early phase trials testing mRNA-based HIV vaccines.

Years Ahead in HIV Prevention Research: Time to Market

This new timeline shows the potential time points when the next-generation of HIV prevention options might find their way into new programs.

Pregnant and Lactating People (PLP) in Ongoing HIV Prevention Trials

Current trends for investment in HIV prevention R&D by technology

Overall numbers by year. For more detailed information, visit www.hivresourcetracking.org.

Status Updates on Ongoing and Planned HIV Prevention Trials

The world is grappling with the far-reaching impacts of the COVID-19 pandemic and the HIV prevention field is no different. Most trials investigating new biomedical HIV prevention products have paused, citing concerns for the safety of trial...

Ongoing Studies for the Treatment and Prevention of the COVID-19 Virus

This table is a work in progress, as this is an incredibly dynamic landscape. Over the past month, the scientific community has accelerated development of COVID-19 diagnostics, therapeutics and a potential vaccine. This document also links to a...

AIDS Vaccines by the Numbers: Trials, discoveries, money and more

We know that an AIDS vaccine is possible and that a vaccine will be an important part of a long-term strategy to end the AIDS epidemic. The road ahead is long, but clinical trials—even those with disappointing results—and early-stage research...

The HIV Prevention Pipeline

This graphic shows currently available options for HIV prevention, newly approved and recommended treatment, and those in development.

The Years Ahead in Biomedical HIV Prevention Research

This graphic shows the updated status of large-scale prevention trials through 2024.

HIV Vaccines: An introductory factsheet

This is an updated introductory two-page document that describes HIV vaccines research and reviews key developments in the field.